This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anne Ollis - Innovator in Glycosylation Enzymes
Introduction
Anne Ollis is an accomplished inventor based in Collegeville, PA (US). She is currently associated with GlaxoSmithKline Biologicals SA, where she contributes to advancements in biotechnology. Despite having no granted patents to her name, her work in the field of oligosaccharyltransferase enzymes is noteworthy.
Latest Patent Applications
Anne Ollis has filed a patent application for "MUTATED PGLB OLIGOSACCHARYLTRANSFERASE ENZYMES." This application details the development of mutated PglB oligosaccharyltransferase enzymes that efficiently catalyze the transfer of a saccharide from a lipid carrier to an asparagine residue in a glycosylation motif on a protein. The application also includes polynucleotides encoding these mutated enzymes, host cells capable of expressing them, and methods for using these engineered enzymes to produce N-glycosylated proteins. Additionally, it describes the N-glycosylated proteins made using these engineered enzymes.
Conclusion
Anne Ollis is making significant contributions to the field of biotechnology through her innovative research on glycosylation enzymes. Her work has the potential to impact various applications in protein engineering and therapeutic development.